Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

8-K

SEC Filing Details

Document Details

Form
Filing Date
May 11, 2017
Document Date
May 9, 2017
Form Description

Report of unscheduled material events or corporate event

Filing Group
Current Reports
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved